Frankfurt - Delayed Quote EUR

Redcare Pharmacy NV (RDC.F)

Compare
146.20 +0.70 (+0.48%)
As of 11:42 AM GMT+1. Market Open.
Loading Chart for RDC.F
DELL
  • Previous Close 145.50
  • Open 145.60
  • Bid 146.70 x --
  • Ask 147.00 x --
  • Day's Range 145.60 - 146.30
  • 52 Week Range 95.95 - 170.90
  • Volume 251
  • Avg. Volume 722
  • Market Cap (intraday) 2.928B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) --
  • EPS (TTM) -1.32
  • Earnings Date Nov 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 159.17

Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.

www.redcare-pharmacy.com

1,725

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RDC.F

View More

Performance Overview: RDC.F

Trailing total returns as of 11/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RDC.F
11.60%
DAX P
15.59%

1-Year Return

RDC.F
16.26%
DAX P
20.79%

3-Year Return

RDC.F
2.66%
DAX P
21.94%

5-Year Return

RDC.F
297.82%
DAX P
47.09%

Compare To: RDC.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RDC.F

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    2.91B

  • Enterprise Value

    2.95B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.31

  • Price/Book (mrq)

    5.77

  • Enterprise Value/Revenue

    1.32

  • Enterprise Value/EBITDA

    60.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.10%

  • Return on Assets (ttm)

    -0.86%

  • Return on Equity (ttm)

    -4.56%

  • Revenue (ttm)

    2.23B

  • Net Income Avi to Common (ttm)

    -24.56M

  • Diluted EPS (ttm)

    -1.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    209.9M

  • Total Debt/Equity (mrq)

    45.60%

  • Levered Free Cash Flow (ttm)

    -4.45M

Research Analysis: RDC.F

View More

Company Insights: RDC.F

Research Reports: RDC.F

View More

People Also Watch